The 'Niche Solutions' of Value-based Care, per Doug Chaet of Value Evolutions
October 19th 2022Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing and CMS value-based trends vs commercial payer trends. Chaet also addressed the status of select payment models like bundled and episodic, and more.
Watch
Doug Chaet of Value Evolutions Sees Value-based Care Programs as Just That: an Evolution
October 18th 2022Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing and CMS value-based trends vs commercial payer trends.
Watch
Why Value-based Contracts Are Still the Exception, per Chester "Bernie" Good at UPMC
October 17th 2022Chester "Bernie" Good, senior medical director for the Center for Value Based Pharmacy Initiatives at UPMC Health Plan, gets in depth on value-based contracts and shares the results of the 2019 contract between UPMC and AstraZeneca for Brilinta. Good addressed value-based contracts last week at AMCP Nexus 2022 conference in National Harbor, Maryland.
Watch
How to Make Accumulator, Maximizer Programs More Acceptable to Your Patients l AMCP Nexus 2022
October 14th 2022Julie Kendle, Director, Clinical Pharmacy Director, Clinical Pharmacy at IPD Analytics addresses tips on improving accumulators and ways for PBMs or payers to make their accumulator and maximizer programs more acceptable to patients. Kendle spoke at this year's AMCP Nexus meeting in National Harbor, Maryland.
Watch
Digital Therapeutics Should Have More to Come in Healthcare by 2023 | AMCP Nexus 2022
October 13th 2022Kelly Price, vice president of market access for Mahana Therapeutics, compared the difference between digital therapeutics, prescription digital therapeutics and how FDA approval factors into that difference. She also shared what's hopeful and what's to come as far as coverage decisions, rule changes and FDA guidance for digital therapeutics in 2023.
Watch
What You Need To Know About Medicare Part B Step Therapy: AMCP Nexus 2022
October 12th 2022Yuqian Liu, Pharm.D., and Michelle Booth, Pharm.D., of Magellan Rx Management, discuss the background and consequences of step therapy in Medicare Part B in an interview prior to their session at the AMCP Nexus 2022 meeting in National Harbor, Maryland.
Watch
Some Humira Biosimilar Customers Are Taking a Wait-and-See Approach
October 6th 2022Tom Newcomer, head of U.S. market access for Samsung Bioepis, maker of Hadlima, a Humira biosimilar, said some potential customers want to see which biosimilars will grab a large market share before deciding on which one to buy
Watch